Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102219792A details a green, high-yield synthesis of prasugrel intermediates via Grignard reaction and thermal decomposition, offering significant cost reduction.
Novel synthesis route for angiotensin II receptor antagonist intermediates offering improved yield and purity for pharmaceutical manufacturing.
Patent CN106434611A details a high-yield enzymatic route for L-Ornithine, offering superior purity and supply chain stability for nutritional and pharmaceutical applications.
Advanced enzymatic resolution process for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers.
Patent CN1205196C reveals a novel C(10) selective acylation method for 10-DAB. Discover cost-effective taxane intermediate manufacturing and supply chain advantages.
Patent CN105399728B reveals high-yield R-lansoprazole production. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners globally.
Patent CN110407846A reveals high-purity 5-ISMN synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN100338078C reveals high-purity phosphorodiamidite production reducing diester impurities for reliable oligonucleotide intermediate supply chains.
Patent CN102190642B reveals a novel Prins reaction route for Corey lactone. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107759619B reveals a mild organocatalytic route for dihydropyrano-thiazoles, offering high yields and stereocontrol for reliable pharmaceutical intermediate supply chains.
Patent CN102336676A reveals a novel arylmethyl protection strategy for Dopexamine Hydrochloride, offering mild deprotection conditions and superior supply chain reliability for pharmaceutical manufacturers.
Patent CN108948080B reveals a safer triethylsilane-based route for fosaprepitant dimeglumine, offering high purity and scalable manufacturing for global supply chains.
Patent CN116761809A discloses Fmoc solid-phase synthesis for ACTH. Achieves 99% purity and 63% yield. Ideal for reliable API intermediate supplier partnerships.
Discover the polymer-supported synthesis of Combretastatin A-4 via patent CN100343216C. Achieve high Z-selectivity and simplified purification for scalable pharmaceutical manufacturing.
Patent CN107056796B details a novel copper-catalyzed synthesis route offering high stereoselectivity and simplified processing for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN109748950B reveals a novel Pd-catalyzed solid-phase method for Selepressin, offering high purity and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN103360292B offers safe ethanol-based route for Febuxostat intermediate ensuring high purity and scalable supply chain stability for global buyers.
Patent CN103936691B reveals solid-phase synthesis for high-purity thiadiazole intermediates. Reduces cost and lead time for pharmaceutical manufacturing supply chains.
Novel hydroboration-oxidation route enhances purity and scalability for tetrahydro-2H-pyran-3-one manufacturing, offering supply chain stability.
Novel patent CN106554371A offers low-cost TNF preparation. Enhances supply chain reliability and purity for pharmaceutical intermediates manufacturing processes globally.